NIOX Group Plc (LON:NIOX – Get Free Report) reached a new 52-week low during trading on Monday . The company traded as low as GBX 56.65 ($0.73) and last traded at GBX 65.89 ($0.85), with a volume of 4448223 shares trading hands. The stock had previously closed at GBX 62.80 ($0.81).
NIOX Group Trading Down 2.7 %
The company has a quick ratio of 1.94, a current ratio of 6.31 and a debt-to-equity ratio of 1.10. The company has a market cap of £26.53 billion, a price-to-earnings ratio of 2,665.93 and a beta of 0.92. The firm has a 50 day moving average price of GBX 61.67 and a two-hundred day moving average price of GBX 63.83.
Insider Transactions at NIOX Group
In other NIOX Group news, insider Jonathan Emms bought 31,604 shares of the business’s stock in a transaction that occurred on Wednesday, December 18th. The shares were bought at an average price of GBX 63 ($0.81) per share, for a total transaction of £19,910.52 ($25,664.50). Corporate insiders own 46.72% of the company’s stock.
About NIOX Group
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.
Read More
- Five stocks we like better than NIOX Group
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Why Invest in High-Yield Dividend Stocks?
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Expert Stock Trading Psychology Tips
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for NIOX Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NIOX Group and related companies with MarketBeat.com's FREE daily email newsletter.